Electrolyte Abnormalities in Cancer

  • Manuel Martinez-Maldonado
  • Julio E. Benabe
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 252)


This review will briefly discuss various electrolyte disturbances that occur in patients suffering from cancer. We will highlight those alterations in plasma composition that are directly due to the presence of tumor, indeed, substances produced by tumors may be responsible for the production of various alterations in plasma composition including changes in the concentration of sodium, potassium, calcium and phosphate.


Multiple Myeloma Tumor Lysis Syndrome Osteoclastic Bone Resorption Isolate Clinical Syndrome Nephrogenic Diabetes Insipidus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Martlnez-Maldonado, and L. Bäez-Diaz, Renal Involvement in Multiple Myxoma, in: Nephrology, Vol. II, Proceedings of the IX International Congress of Nephrology, R.R. Robinson, ed., Springer-verlag, New York (1984).Google Scholar
  2. 2.
    J.P. Jaffe, and D.F. Mosher, Calcium binding by myeloma proteins, Am J Med 67:343–346 (1979).PubMedCrossRefGoogle Scholar
  3. 3.
    S.G. Adler, S.A. Laidlaw, M.M. Lubran, Hyperglobulinemia may spuriously elevate measured inorganic phosphate, abstracted. Kidney Int 25:157 (1984).Google Scholar
  4. 4.
    J.C. Busse, M.A. Gelbard, J.J. Byrnes, R. Hellman, C.A. Vaamonde, Pseudohyperphosphatemia and dysproeinemia. Arch Intern Med 147:2045–2046 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    W.R. Bronson, V.T. Devita, P.P. Carboneand E. Cotlove, Pseudohyperkalemia due to release of potassium from white blood cells during clotting, N Engl J Med 274:369–373 (1966).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Martlnez-Maldonado, Idiopathic syndrome of inappropriate antidiuretic hormone secretion. Kidney Int 17 (4):126–140 (1980).Google Scholar
  7. 7.
    J.E. Benabe, and M. Martlnez-Maldonado, Hypercalcemic nephropathy. Arch Intern Med 138:777–779 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    M. Fichman, and J. Bethune, Effects of neoplasms on renal electrolyte function, Ann NY Acad Sci 230:448–471 (1974).PubMedCrossRefGoogle Scholar
  9. 9.
    D. Farge, G. Chatellier, J.Y. Pagny, X Jeunemaitre, P.F. Plouin, P. Corval, isolated clinical syndrome of primary aldosteronism in four patients with adrenocortical carcinoma, Am J Med 83:635–640 (1987).PubMedCrossRefGoogle Scholar
  10. 10.
    F.M. Muggia, H.O. Heinemann, M. Farhangi, and E.F. Osserman, Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med 47:351–366 (1969).PubMedCrossRefGoogle Scholar
  11. 11.
    G.C. Tsokos, J.E. Balow, R.J. Spiegel, and I.T. Magrath, Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine 60:218–229 (1981).PubMedCrossRefGoogle Scholar
  12. J.P. Knöchel, The pathophysiology and clinical characteristics of severe hypophosphatemia, Arch intern Med 137:203–220 (1977).PubMedCrossRefGoogle Scholar
  13. 13.
    M. Mart inez-Maldonado, J. Yium, W. Suki, and G.E. Eknoyan, Renal complications in multiple myeloma: Pathophysiology and some aspects of clinical management, J Chronic Dis 24:221–237 (1971).CrossRefGoogle Scholar
  14. 14.
    D.J. Leehey, T.S. Ing, and J.T. Daugirdas, Fanconi syndrome associated with a non-ossifying fibroma of bone, Am J Med 78:708–710 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    E.A. Ryan, and E. Reiss, Oncogenous osteomalacia: Review of the world literature of 42 cases and report of two new cases, Am J Med 77:501–512 (1984).PubMedCrossRefGoogle Scholar
  16. 16.
    F. Lustman, R. Parmentier, and P. Dustin, Oncogenic osteomalacia and renal adenoid dysplasia, Ann intern Med 102:869–870 (1985).PubMedGoogle Scholar
  17. 17.
    M.K. Drezner, and M.N. Feinglos, Osteomalacia due to 1 α, 25 dihydroxycholecalciferol deficiency: Association with giant cell tumor of bone, J Clin Invest 60:1046–1053 (1977).PubMedCrossRefGoogle Scholar
  18. 18.
    G.S. Lazar, and D.I. Feinstein, Distal renal tubular acidosis in multiple myeloma. Arch Intern Med 141:655–657 (1981)PubMedCrossRefGoogle Scholar
  19. 19.
    R.C. Morris, Jr, and H.H. Fudenberg, impaired renal acidification in patients with hypergammaglobulinemia. Medicine 46:57–62 (1967).PubMedCrossRefGoogle Scholar
  20. 20.
    G.J. Roth, and D. Porte Jr, Chronic lactic acidosis and acute leukemia. Arch Intern Med 125:317–321 (1970).PubMedCrossRefGoogle Scholar
  21. 21.
    K. Rice, and S.H. Schwartz, Lactic acidosis with small cell carcinoma: Rapid response to chemotherapy. Am J Med 79:501–503 (1985).PubMedCrossRefGoogle Scholar
  22. 22.
    J. Zusman, D.M. Brown, and M.E. Nesbit, Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia, J Engl J Med 289:1335–1340 (1973).CrossRefGoogle Scholar
  23. 23.
    L.F. Cohen, J.E. Balow, I.T. Magrath, D.G. Poplack, and J.L. Ziegler, Acute tumor lysis syndrome: A review of 37 patients with Burkitt’s lymphoma. Am J Med 68:486–491 (1980).PubMedCrossRefGoogle Scholar
  24. 24.
    G.R. Mundy, K.J. Ibbotson, S.M. D’Souza, E.L. Simpson, J.W. Jacobs, and T.J. Martin, The hypercalcemia of cancer: Clinical implications and pathogenic mechanisms, N Engl J Med 310:1718–1726 (1984).PubMedCrossRefGoogle Scholar
  25. 25.
    G.R. Mundy, The hypercalcemia of malignancy. Kidney Int 31:142–155 (1987).PubMedCrossRefGoogle Scholar
  26. 26.
    N.A. Breslau, J.L. McGuire, J.E. Zerwekh, E.P. Frenkel and C.Y.Z. Pak, Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma, N Engl J Med 100:1–7 (1984).Google Scholar
  27. 27.
    D.A. Fetchick, D.R. Bertolini, P. Sarin, G.R. Mundy, and J.F. Dunn, Metabolism of 25-hydroxyvitamin D by human T cell lymphotrophic virus-transformed cord blood lymphocytes, J Bone Miner Res 1:323 (1986).Google Scholar
  28. 28.
    H.I. Scher, and A. Yagoda, Bone metastases: Pathogenesis, treatment and rationale for use of resorption inhibitors, Am J Med 82 (Suppl 2A):6–28 (1987).PubMedCrossRefGoogle Scholar
  29. 29.
    J. Hon, G.R. Mundy, R. Derynck, and G.D. Roodman, Recombinant human transforming growth factor (TGF-α) stimulates the formation of osteoclast (OCL) -like cells in long term human marrow cultures, J Bone Miner Res 1:68 (1986).Google Scholar
  30. 30.
    A.H. Tashjian Jr, E.F. Voelkel, W. Lloyd, R. Derynck, M.E. Winkler and L. Levine, Actions of growth factors on plasma calcium, J Clin Invest 78:1405–1409 (1986).PubMedCrossRefGoogle Scholar
  31. 31.
    N. Horiuchi, M.P. Caulfield, J.E. Fisher, M.E. Goldman, R.L. McKee, J.E. Reagan, J.J. Levy, R.F. Nutt, S.B. Rodan, T.L. Schofield, T.L. Clemens, M. Rosenblatt, Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science 238:1566–1568 (1987).PubMedCrossRefGoogle Scholar
  32. 32.
    B.E. Kemp, J.M. Moseley, C.P. Rodda, P.R. Ebeling, R.E.H. Wettenhall, D. Stapleton, H. Diffenbach-Jagger, F. Ure, V.P. Michelangeli, H.A. Simmons, L.G. Raisz, T.J. Martin, Parathyroid hormone-related protein of malignancy: Active synthetic fragments. Science 238:1568–1570 (1987).PubMedCrossRefGoogle Scholar
  33. 33.
    J.J. Merendino, Jr, K.L. Insogna, L.M. Milstone, A.E. Broadus, and A.F. Stewart, A parathyroid hormone-like protein from cultured human keratinocytes, Science 231:388–390 (1986).PubMedCrossRefGoogle Scholar
  34. 34.
    K.J. Ibbotson, D.R. Twardzik, S.M. D’Souza, W.R. Hargreaves, G.J. Todaro, G.R. Mundy, Stimulation of bone resorption in vitro by synthetic transforming growth factor-alpha. Science 228:1007–1009 (1985).PubMedCrossRefGoogle Scholar
  35. 35.
    K.J. Ibbotson, J. Harrod, M. Gowen, Effects of human transforming growth factor (TGF) alpha on bone resorption and formation in vitro, Proc Natl Acad Sci USA 83:2228–2232 (1986).PubMedCrossRefGoogle Scholar
  36. 36.
    P.M.J. McSheehy, and T.J. Chambers, 1, 25-Dihydroxyvitamin stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption, J Clin invest 80:425–429 (1987).PubMedCrossRefGoogle Scholar
  37. 37.
    K. Sato, H. Mimura, D.C. Han, T. Kakiuchi, Y. Ueyama, H. Ohkawa, T. Okabe, Y. Kondo, N. Ohsawa, T. Tsushima, K. Shizume, Production of bone resocbing activity and colony stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis, Clin invest 78:145–154, 1986.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Manuel Martinez-Maldonado
    • 1
    • 2
  • Julio E. Benabe
    • 1
    • 2
  1. 1.Renal Section, Medical ServiceVeterans Administration Medical CenterPuerto Rico
  2. 2.Departments of Medicine & PhysiologyUniversity of Puerto Rico School of MedicinePuerto Rico

Personalised recommendations